O'Leary James J 4
4 · Fusion Pharmaceuticals Inc. · Filed Feb 8, 2021
Insider Transaction Report
Form 4
O'Leary James J
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-04+114,000→ 114,000 totalExercise: $11.90Exp: 2031-02-03→ Common Stock (114,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on February 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.